专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07049343B2 Substituted hydrazine derivatives 失效
公开(公告)号：US07049343B2
公开(公告)日：2006-05-23
申请号：US10344966
申请日：2001-09-07
申请人： Syed M. Ali , Kurt R. Brunden , Dario Doller , Brian Herbert , Jack B. Jiang , Amy Jordan
发明人： Syed M. Ali , Kurt R. Brunden , Dario Doller , Brian Herbert , Jack B. Jiang , Amy Jordan
IPC分类号： A01N74/34 , A61K31/175
CPC分类号： C07C243/38 , C07C243/22 , C07C243/28 , C07C243/34 , C07C255/24 , C07C255/66 , C07C259/06 , C07C327/44 , C07D231/08
摘要： A method for the inhibition of high affinity glycine transporters, compounds that inhibit these transporters; pharmaceutically active compositions comprising such compounds; and the use of such compounds either as above, or in formulations for the control or prevention of disease states in which glycine is involved are disclosed.

2. 发明授权

US06946474B2 Nitrogen-containing compounds and their use as glycine transport inhibitors 失效
标题翻译：含氮化合物及其作为甘氨酸转运抑制剂的用途
公开(公告)号：US06946474B2
公开(公告)日：2005-09-20
申请号：US10344962
申请日：2001-09-13
申请人： Syed M. Ali , Kurt R. Brunden , Jack B. Jiang
发明人： Syed M. Ali , Kurt R. Brunden , Jack B. Jiang
IPC分类号： A61K31/165 , A61K31/166 , A61K31/17 , A61K31/192 , A61K31/195 , A61K31/196 , A61K31/215 , A61K31/223 , A61K31/245 , A61K31/381 , A61K31/41 , A61K31/415 , A61K31/4152 , A61K31/428 , A61K31/47 , A61K31/4706 , A61P21/00 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/18 , A61P25/28 , A61P43/00 , C07C335/08 , C07C335/16 , C07C335/22 , C07D213/75 , C07D215/40 , C07D231/22 , C07D257/04 , C07D257/06 , C07D277/62 , C07D211/72 , C07D211/84 , C07D213/72 , C07D231/38 , C07D231/75
CPC分类号： C07D213/75 , A61K31/165 , A61K31/166 , A61K31/195 , A61K31/215 , A61K31/381 , A61K31/41 , A61K31/415 , A61K31/4706 , C07C335/08 , C07C335/16 , C07C335/22 , C07C2601/02 , C07C2601/14 , C07D215/40 , C07D231/22 , C07D257/06
摘要： The present invention provides trichloroethyl-sulfonylurea-containing compounds that inhibit glycing transporters, pharmaceutical compositions comprising such compounds, methods for using such compounds for inhibiting glycine transporters and methods for using such compounds for the treatment of disease states in which glycine is involved.
摘要翻译：本发明提供了抑制糖链转运蛋白的含三氯乙基磺酰脲的化合物，包含这些化合物的药物组合物，使用这些化合物抑制甘氨酸转运蛋白的方法以及使用这些化合物治疗其中涉及甘氨酸的疾病状态的方法。

3. 发明授权

US06794405B2 Alicyclic imidazoles as H3 agents 失效
标题翻译：脂环族咪唑作为H3剂
公开(公告)号：US06794405B2
公开(公告)日：2004-09-21
申请号：US10344787
申请日：2003-08-04
申请人： Yajing Rong , Jack B. Jiang , Syed M. Ali
发明人： Yajing Rong , Jack B. Jiang , Syed M. Ali
IPC分类号： A61K314164
CPC分类号： C07D233/64
摘要： Alicyclic imidazole compounds; pharmaceutically active compositions containing such compounds; and the use of such compounds in formulations for the control or prevention of disease states in which histamine H3 receptors are involved, such as allergy, inflammation, hypotension, glaucoma, sleeping disorders, states of hyper- and hypo-motility of the gastro-intestinal tract, cardiovascular disease, hypo- and hyper-activity of the central nervous system, Alzheimer's, schizophrenia, obesity and migraines are disclosed.
摘要翻译：脂环咪唑化合物; 含有这些化合物的药物活性组合物; 以及这些化合物在制剂中的用途，用于控制或预防其中涉及组胺H3受体的疾病状态，例如过敏，炎症，低血压，青光眼，睡眠障碍，胃肠超和运动不足的状态公开了中枢神经系统，阿尔茨海默病，精神分裂症，肥胖症和偏头痛的低血压，高血压，心脑血管疾病，低血压和高活性。

4. 发明授权

US5216014A Furo-coumarinsulfonamides as protein kinase C inhibitors 失效
标题翻译：呋喃香豆素磺酰胺作为蛋白激酶C抑制剂
公开(公告)号：US5216014A
公开(公告)日：1993-06-01
申请号：US757664
申请日：1991-09-10
申请人： Jack B. Jiang , Mary G. Johnson
发明人： Jack B. Jiang , Mary G. Johnson
IPC分类号： C07D493/04 , C07D519/00
CPC分类号： C07D493/04
摘要： The present invention provides novel furocoumarinsufonamide derivatives having the formula ##STR1## wherein R.sub.1, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are independently H or lower alkyl; m, n and p are independently 2, 3, 4, 5 or 6; A is NR.sub.4 (CH.sub.2).sub.P NR.sub.5, NR.sub.6, O or S; R.sub.2 is independently H, lower alkyl or a moiety of the formula ##STR2## useful for inhibiting protein kinase C and treating conditions related to, or affected by inhibition of protein kinase C, particularly cancer tumors, inflammatory disease, reperfusion injury, and cardiac dysfunctions related to reperfusion injury.
摘要翻译：本发明提供具有下式的新型呋喃香豆素磺酰胺衍生物：其中R 1，R 3，R 4，R 5和R 6独立地为H或低级烷基; m，n和p分别为2,3,4,5或6; A是NR4（CH2）PNR5，NR6，O或S; R2独立地是H，低级烷基或可用于抑制蛋白激酶C的式“IMAGE”的部分，并且治疗与抑制蛋白激酶C，特别是癌症肿瘤，炎性疾病，再灌注损伤和心脏功能障碍有关或受其抑制的条件。与再灌注损伤相关。

5. 发明授权

US5360818A 1,3-dioxane derivatives having protein kinase C inhibitory activity 失效
标题翻译：具有蛋白激酶C抑制活性的1,3-二恶烷衍生物
公开(公告)号：US5360818A
公开(公告)日：1994-11-01
申请号：US110847
申请日：1993-08-24
申请人： Jack B. Jiang , Mary G. Johnson , Jeffrey Nichols
发明人： Jack B. Jiang , Mary G. Johnson , Jeffrey Nichols
IPC分类号： C07D319/06 , A61K31/35 , C07D309/14
CPC分类号： C07D319/06
摘要： The present invention provides compounds having the formula ##STR1## wherein R.sub.1 is alkyl, alkenyl and alkynyl having from 2 to about 20 carbon atoms; R.sub.2, R.sub.3 and R.sub.6 are independently H, phenyl or alkyl having from 1 to about 20 carbon atoms; and R.sub.4 and R.sub.5 are independently H, R.sub.6 imino, or amidino, and pharmaceutically acceptable salts thereof which are useful for inhibiting protein kinase C and treating conditions related to, or affected by inhibition of protein kinase C, particularly cancer tumors, inflammatory disease, reperfusion injury, and cardiac dysfunctions related to reperfusion injury.
摘要翻译：本发明提供了具有式“IMAGE”的化合物，其中R 1是具有2至约20个碳原子的烷基，烯基和炔基; R2，R3和R6独立地为H，苯基或具有1至约20个碳原子的烷基; 和R4和R5独立地是H，R6亚氨基或脒基，及其药学上可接受的盐，其可用于抑制蛋白激酶C，并且治疗与抑制蛋白激酶C特别是癌症肿瘤，炎性疾病，再灌注损伤有关或受其影响的病症，以及与再灌注损伤相关的心脏功能障碍。

6. 发明授权

US5204370A Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C 失效
标题翻译：蛋白激酶C的双 - （羟烷基氨基） - 蒽醌抑制剂
公开(公告)号：US5204370A
公开(公告)日：1993-04-20
申请号：US609252
申请日：1990-11-05
申请人： Jack B. Jiang , Mary G. Johnson
发明人： Jack B. Jiang , Mary G. Johnson
IPC分类号： C07C225/34 , C07C225/36 , C07D303/36
CPC分类号： C07C225/36 , C07C225/34 , C07D303/36
摘要： The present invention provides novel substituted anthraquinones having the formula ##STR1## wherein R.sub.1 and R.sub.2 are independently H, C.sub.1 -C.sub.10 alkyl, aryl, arylalkyl, alkylaryl;n and m are independently 1, 2, or 3;A is Halogen, OH, alkoxy, OCO(NR.sub.3 R.sub.4), S--C(NH.sub.2).dbd.NR.sub.5, or when m=1, comprises an oxirane ring with the adjacent oxygen atom;R.sub.3, R.sub.4, and R.sub.5 are independently H, alkyl, or aryl;X is H, OH, NR.sub.6 R.sub.7, Cl, Br, I, F, alkyl, aryl, alkoxy, aryloxy, COOR.sub.8, or CONR.sub.9 R.sub.10 ; andR.sub.6, R.sub.7, R.sub.8, R.sub.9, and R.sub.10 are independently H, lower alkyl, or aryluseful for inhibiting protein kinase C and treating conditions related to, or affected by inhibition of protein kinase C, particularly cancer tumors, inflammatory disease, reperfusion injury, and cardiac dysfunctions related to reperfusion injury.
摘要翻译：本发明提供具有下式的新的取代的蒽醌：其中R1和R2独立地为H，C1-C10烷基，芳基，芳基烷基，烷基芳基; n和m独立地为1,2或3; A是卤素，OH，烷氧基，OCO（NR 3 R 4），S-C（NH 2）= NR 5，或当m = 1时，包含具有相邻氧原子的环氧乙烷环; R3，R4和R5独立地是H，烷基或芳基; X是H，OH，NR 6 R 7，Cl，Br，I，F，烷基，芳基，烷氧基，芳氧基，COOR 8或CONR 9 R 10; R 6，R 7，R 8，R 9和R 10独立地为可用于抑制蛋白激酶C的H，低级烷基或芳基，并且治疗与抑制蛋白激酶C特别是癌症肿瘤，炎性疾病，再灌注损伤有关或受其影响的条件，以及与再灌注损伤相关的心脏功能障碍。

7. 发明授权

US06307070B1 Substituted aurone derivatives 失效
标题翻译：取代的鸢尾衍生物
公开(公告)号：US06307070B1
公开(公告)日：2001-10-23
申请号：US09122257
申请日：1998-07-24
申请人： Wai-Lam Alex Chu , Flemming R. Jensen , Thomas B. Jensen , James B. McAlpine , Birgitte Søkilde , Alexandra M. SantAna-Sørensen , Sunil Ratnayake , Jack B. Jiang , Catharine Noble , Angela M. Stafford
发明人： Wai-Lam Alex Chu , Flemming R. Jensen , Thomas B. Jensen , James B. McAlpine , Birgitte Søkilde , Alexandra M. SantAna-Sørensen , Sunil Ratnayake , Jack B. Jiang , Catharine Noble , Angela M. Stafford
IPC分类号： C07D30783
CPC分类号： C07D307/82 , A61K31/343 , C07D307/83
摘要： A method for treating a fungal infection is disclosed. The method includes administering to a patient a pharmaceutical composition containing a compound of formula (IA): where each R is independently H, OH, Br, Cl, I, amino, thiol, nitro, C1-4 alkoxy, C1-4 alkenyloxy, C2-6 alkoxyalkyleneoxy, C1-4 alkylthio, C3-18 alkyl, or C3-18 alkenyl; or two adjacent R's, taken together, are a C2-18 bivalent moiety containing at least one oxgen atom, substituted or disubstituted with A or B or both, A being H, OH, Br, Cl, I, amino, or thiol, and B being H, C1-10 alkyl, C2-18 alkenyl, or C6-18 aryl; provided at least two Rs are not H; X is C4-10 alkyl, C4-20 alkenyl, or a C4-20 single, C6-20 bridged, or C6-20 fused ring moiety containing cycloalkyl, cycloalkenyl, aryl, heterocycle, or heteroaryl, where X is substituted with H, OH, Cl, Br, I, amino, cyano, nitro, alkyl, alkoxy, alkenyl, or alkenyloxy; provided that if X is a heteroaryl or heterocyclic moiety where two Rs are each OH and meta to each other, then the remaining R is H and ortho to each of the two hydroxyls, and Y and Z are each O and a ring atom of X is linked directly to the sp2 carbon atom adjacent to X, then substituted with H, OH, Cl, Br, I, amino, cyano, alkyl, alkoxy, alkenyl, or alkenyloxy; and each of Y and Z is independently selected from O, S, and NH; or a pharmaceutically acceptable salt or ester thereof.
摘要翻译：公开了一种治疗真菌感染的方法。该方法包括向患者施用含有式（IA）化合物的药物组合物：其中每个R独立地为H，OH，Br，Cl，I，氨基，硫醇，硝基，C 1-4烷氧基，C 1-4链烯氧基， C 2-6烷氧基亚烷基氧基，C 1-4烷硫基，C 3-8烷基或C 3-8烯基; 或两个相邻的R一起是含有至少一个被A或B或两者取代或二取代的氧原子的C2-18二价部分，A是H，OH，Br，Cl，I，氨基或硫醇，以及 B是H，C 1-10烷基，C 2-8烯基或C 6-18芳基; 提供至少两个R不是H; X是C 4-10烷基，C 4-20链烯基，或含有环烷基，环烯基，芳基，杂环或碳原子的C 4-20单-C6-20桥环或C6-20稠环部分杂芳基，其中X被H，OH，Cl，Br，I，氨基，氰基，硝基，烷基，烷氧基，烯基或烯氧基取代; 条件是如果X是杂芳基或杂环部分，其中两个R 5各自为OH并且彼此相互间隔，则剩余的R是H和两个羟基中的每一个的邻位，Y和Z各自为O，X为环原子直接与X相邻的sp2碳原子连接，然后用H，OH，Cl，Br，I，氨基，氰基，烷基，烷氧基，烯基或烯氧基取代; Y和Z各自独立地选自O，S和NH; 或其药学上可接受的盐或酯。

8. 发明授权

US4656274A Polyfluorinated substituted tricyclic quinoline mono and dioxo antifungal agents and process for their preparation 失效
标题翻译：多氟取代三环喹啉单和二氧抗菌剂及其制备方法
公开(公告)号：US4656274A
公开(公告)日：1987-04-07
申请号：US701008
申请日：1985-02-12
申请人： Jack B. Jiang , David Isaacson
发明人： Jack B. Jiang , David Isaacson
IPC分类号： C07D219/06 , C07D471/04
CPC分类号： C07D219/06 , C07D471/04
摘要： Polyfluorinated substituted quinoline mono- and dioxo compounds and a method for preparing them are described. The fluorinated oxo compounds are useful as antifungal agents.
摘要翻译：描述了多氟化取代喹啉单和二氧化合物及其制备方法。氟化氧化合物可用作抗真菌剂。

9. 发明授权

US4602013A Substituted 2-amino-4(1H)pyridones, 7-pyrrolo[1,2-a]pyridinones, 2-quinolizinones, 7-thiazolo[3,2-a]pyridinones and 2-pyrido[1,2-a]azepinones as vasodilators and bronchodilators 失效
标题翻译：取代的2-氨基-4（1H）吡啶酮，7-吡咯并[1,2-a]吡啶酮，2-喹嗪酮，7-噻唑并[3,2-a]吡啶酮和2-吡啶并[1,2-a]吖庚因作为血管扩张剂和支气管扩张剂
公开(公告)号：US4602013A
公开(公告)日：1986-07-22
申请号：US578259
申请日：1984-02-08
申请人： Jack B. Jiang
发明人： Jack B. Jiang
IPC分类号： C07D213/73 , C07D213/74 , C07D455/02 , C07D471/04 , C07D513/04 , A61K31/55 , C07D221/04
CPC分类号： C07D213/73 , C07D213/74 , C07D455/02 , C07D471/04 , C07D513/04
摘要： Substituted 2-amino-4(1H)pyridones are provided which are renal vasodilators and bronchodilators.
摘要翻译：提供了取代的2-氨基-4（1H）吡啶酮，其是肾血管扩张剂和支气管扩张剂。

10. 发明授权

US07119217B2 Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them 失效
标题翻译：三（烷基羧基）镓（III）产品和含有它们的药物组合物
公开(公告)号：US07119217B2
公开(公告)日：2006-10-10
申请号：US10668473
申请日：2003-09-22
申请人： Jack B. Jiang , Raymond P. Warrell, Jr. , Kollengode K. Ramaswamy , Robert E. Klem
发明人： Jack B. Jiang , Raymond P. Warrell, Jr. , Kollengode K. Ramaswamy , Robert E. Klem
IPC分类号： C07F5/00 , A61K33/24 , A61K31/28
CPC分类号： C07C51/412 , C07C53/126 , C07F5/003
摘要： Provided are novel tri(alkylcarboxylato) gallium (III) compounds, exemplified by tripalmitato gallium (III), methods for making them, pharmaceutical compositions containing them, and methods of using the pharmaceutical compositions.
摘要翻译：提供了新颖的三（烷基羧基）镓（III）化合物，其例子是三异氰酸镓（III），其制备方法，含有它们的药物组合物和使用该药物组合物的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式